Tirzepatide

CAS Number: 2023788-19-2 
Purity: ≥99% (Janoshik Verified) 
Form: Lyophilized (freeze-dried) powder 
Size: [5mg] or [10mg] or [20mg] or [50mg]

Description

Tirzepatide is a synthetic dual agonist peptide targeting both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. It is currently being studied in metabolic research for its potential to support glycemic control, body weight modulation, and insulin sensitivity in preclinical models.

Due to its dual action and extended half-life, Tirzepatide is a subject of interest in comparative research involving incretin-based peptide therapeutics. It is provided as a sterile lyophilized powder for non-clinical, laboratory use only.

Storage Instructions

• For long term storage, keep lyophilized peptide at -20°C in a dry, dark place

• After reconstitution, store at 2–8°C and use within a limited timeframe

• Avoid exposure to light and repeated freeze-thaw cycles

Reconstitution

Reconstitute using sterile bacteriostatic water or suitable research-grade solvent. Final concentration depends on intended research protocol.

Important Notice

• For laboratory research use only

• Not for human or veterinary consumption

• Not approved by Health Canada or any regulatory authority for clinical use